Bladder cancer funding analyzer launched on bladder cancer website
Amsterdam, NL, February 16, 2017 – Bladder Cancer (BLC) is proud to announce the launch of the Bladder Cancer Funding Analyzer (BCFA) on the BLC website. It is a free service that is part of a new suite of online features that have been designed to serve the needs of the bladder cancer research community.
BCFA presents in-depth data on more than fifty funders from over twenty countries including the United States, all of the European Union, the United Kingdom, Canada and Japan. It allows users to easily locate funding related to bladder cancer and analyze funding streams and trends. Further, it facilitates a better understanding of research organizations' funding portfolios and the funding patterns of specific funders, both of which are critical when developing grant applications.
"This is a unique and remarkable tool that will be very valuable to everyone doing bladder cancer research," explained BLC's Editors-in-Chief Seth P. Lerner, MD, and Dan Theodorescu, MD, PhD. "It is becoming increasingly important to know more about the funding landscape and about who is working on what project so effective collaborations can be sought out."
Built by ÜberResearch, a solutions and services company focused on the needs of science funders, BCFA includes all funding related to bladder cancer drawn from ÜberResearch's extensive grant database of more than $1.1 trillion of funded research, representing over 3.4 million projects from 258 different funders like the National Institutes of Health and the National Science Foundation in the U.S. and the Wellcome Trust and U.K. Research Councils in the U.K.
Users can conduct line-of-investigation queries (e.g., epithelial-mesenchymal transition, gemcitabine-cisplatin therapy, urinary diversion) to look for funding trends and to see which investigators in which countries have been the most successful in obtaining funding in a given area of bladder cancer research. New funding information will be added to BCFA on an ongoing basis.
"We invite all bladder cancer researchers to access this valuable service at http://www.bladdercancerjournal.com/funding, which we are pleased to make available at no charge," added Dr. Lerner and Dr. Theodorescu.
Wilbert van der Sluijs